Cymbalta Gets FDA Approval For Fibromyalgia

Eli Lilly antidepressant approved for new use
BUSINESSWEEK
The Associated Press June 16, 2008, 4:41PM ET
Eli Lilly antidepressant approved for new use

Eli Lilly and Co. said Monday it received Food and Drug Administration approval to expand the use of its fastest-growing drug, the antidepressant Cymbalta.

Regulators approved Cymbalta to treat fibromyalgia, a chronic pain disorder. The drug already is approved for diabetic nerve pain, major depressive disorder and generalized anxiety disorder.

More…